The study’s aim was to empirically derive the psychopathological constellation associated with self-centrality (i.e. non-delusional self-referential attitude) by seeking an interpretation in the light of the ‘Basic Symptoms Model’ of schizophrenic psychopathology. Eighty-four patients with an established schizophrenic illness receiving maintenance treatment at the Psychiatry Section of the Parma University Neuroscience Department were examined. The Scales for the Assessment of Positive and Negative Symptoms, the Calgary Depression Scale and the Toronto Alexithymia Scale were administered to all subjects to determine levels of positive, disorganized, negative and depressive symptoms, as well as alexithymia. Subjective experiences, including non-delusional self-centrality, were explored by means of the Bonn Scale for the Assessment of Basic Symptoms. Logistic regression detected three different psychopathological domains (delusional, alexithymic, and basic body symptoms) strongly associated with self-centrality. Among these the most influential independent variable was basic body symptoms. These results suggest that impaired lived body experience (i.e. protopathic body disattunement) is a psychopathologic condition concomitant with the emergence of autocentric polarization of experience (i.e. self-centrality).

Keywords:
Self-Centrality, Basic symptoms, Schizophrenia, psychopathology
This content is only available via PDF.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.